Published in Acta Neuropathol on November 05, 2002
Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma. Cancer Cell (2009) 3.11
Expression of the neurogenic basic helix-loop-helix transcription factor NEUROG1 identifies a subgroup of medulloblastomas not expressing ATOH1. Neuro Oncol (2007) 1.10
Nerve growth factor in cancer cell death and survival. Cancers (Basel) (2011) 0.96
Neuronal apoptosis by prolyl hydroxylation: implication in nervous system tumours and the Warburg conundrum. J Cell Mol Med (2009) 0.82
Inhibition of ERβ induces resistance to cisplatin by enhancing Rad51-mediated DNA repair in human medulloblastoma cell lines. PLoS One (2012) 0.79
Protein kinase B alpha/Akt1 regulates placental development and fetal growth. J Biol Chem (2003) 3.27
Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies. Nat Biotechnol (2010) 3.07
Association between inadequate sleep and insulin resistance in obese children. J Pediatr (2007) 2.76
Urinary clusterin, cystatin C, beta2-microglobulin and total protein as markers to detect drug-induced kidney injury. Nat Biotechnol (2010) 2.00
Sonic hedgehog and insulin-like growth factor signaling synergize to induce medulloblastoma formation from nestin-expressing neural progenitors in mice. Oncogene (2004) 1.96
Detection of JC virus DNA fragments but not proteins in normal brain tissue. Ann Neurol (2008) 1.82
Class III beta-tubulin in human development and cancer. Cell Motil Cytoskeleton (2003) 1.76
Puralpha is essential for postnatal brain development and developmentally coupled cellular proliferation as revealed by genetic inactivation in the mouse. Mol Cell Biol (2003) 1.71
Class III beta-tubulin isotype: a key cytoskeletal protein at the crossroads of developmental neurobiology and tumor neuropathology. J Child Neurol (2003) 1.66
A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function. Nat Biotechnol (2010) 1.62
5q14.3 deletion manifesting as mitochondrial disease and autism: case report. J Child Neurol (2010) 1.56
Association of human polyomavirus JCV with colon cancer: evidence for interaction of viral T-antigen and beta-catenin. Cancer Res (2002) 1.54
Transcriptional regulation of HIV-1 gene expression by p53. Cell Cycle (2010) 1.47
Ocular compression pressure during EEG for the study of increased vagal reactivity. Epileptic Disord (2008) 1.40
Human neurotropic polyomavirus, JCV, and its role in carcinogenesis. Oncogene (2003) 1.39
Cerebral meningioangiomatosis in a CD-1 mouse: a case report and comparison with humans and dogs. Exp Toxicol Pathol (2008) 1.37
JC virus-induced changes in cellular gene expression in primary human astrocytes. J Virol (2003) 1.36
Interaction of alpha9beta1 integrin with thrombospondin-1 promotes angiogenesis. Circ Res (2007) 1.28
HIV-1 Tat protein promotes neuronal dysfunction through disruption of microRNAs. J Biol Chem (2011) 1.28
BAG3 protein is overexpressed in human glioblastoma and is a potential target for therapy. Am J Pathol (2011) 1.27
Inhibition of p66ShcA longevity gene rescues podocytes from HIV-1-induced oxidative stress and apoptosis. J Biol Chem (2009) 1.24
CCL8/MCP-2 is a target for mir-146a in HIV-1-infected human microglial cells. FASEB J (2010) 1.23
Activation of the oxidative stress pathway by HIV-1 Vpr leads to induction of hypoxia-inducible factor 1alpha expression. J Biol Chem (2009) 1.21
Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells. Oncogene (2002) 1.21
Role of the insulin-like growth factor I/insulin receptor substrate 1 axis in Rad51 trafficking and DNA repair by homologous recombination. Mol Cell Biol (2003) 1.21
Evidence for BAG3 modulation of HIV-1 gene transcription. J Cell Physiol (2007) 1.20
Inhibition of SNAP25 expression by HIV-1 Tat involves the activity of mir-128a. J Cell Physiol (2008) 1.19
Deregulation of microRNAs by HIV-1 Vpr protein leads to the development of neurocognitive disorders. J Biol Chem (2011) 1.17
ROS accumulation and IGF-IR inhibition contribute to fenofibrate/PPARalpha -mediated inhibition of glioma cell motility in vitro. Mol Cancer (2010) 1.15
Dyad of CD40/CD40 ligand fosters neuroinflammation at the blood-brain barrier and is regulated via JNK signaling: implications for HIV-1 encephalitis. J Neurosci (2010) 1.12
Tubulin-mediated binding of human immunodeficiency virus-1 Tat to the cytoskeleton causes proteasomal-dependent degradation of microtubule-associated protein 2 and neuronal damage. J Neurosci (2006) 1.12
Study of the regression process in cardiac rhabdomyomas. Pediatr Dev Pathol (2002) 1.10
Role for tumor necrosis factor-α in JC virus reactivation and progressive multifocal leukoencephalopathy. J Neuroimmunol (2010) 1.10
Alterations of DNA damage repair pathways resulting from JCV infection. Virology (2007) 1.10
Interferon regulatory factor 4 is involved in Epstein-Barr virus-mediated transformation of human B lymphocytes. J Virol (2008) 1.09
Class III beta-tubulin is constitutively coexpressed with glial fibrillary acidic protein and nestin in midgestational human fetal astrocytes: implications for phenotypic identity. J Neuropathol Exp Neurol (2008) 1.09
T-antigen of the human polyomavirus JC attenuates faithful DNA repair by forcing nuclear interaction between IRS-1 and Rad51. J Cell Physiol (2006) 1.08
Activation of PPARalpha inhibits IGF-I-mediated growth and survival responses in medulloblastoma cell lines. Int J Cancer (2008) 1.08
Acute disseminated encephalomyelitis in children: discordant neurologic and neuroimaging abnormalities and response to plasmapheresis. Pediatrics (2005) 1.07
Intracellular approach for blocking JC virus gene expression by using RNA interference during viral infection. J Virol (2004) 1.06
Targeting sphingosine kinase induces apoptosis and tumor regression for KSHV-associated primary effusion lymphoma. Mol Cancer Ther (2013) 1.05
Interferon regulatory factor 7 is associated with Epstein-Barr virus-transformed central nervous system lymphoma and has oncogenic properties. J Virol (2004) 1.05
Early growth response-1 protein is induced by JC virus infection and binds and regulates the JC virus promoter. Virology (2008) 1.05
Modulation of JC virus transcription by C/EBPbeta. Virus Res (2009) 1.05
Human polyomaviruses and brain tumors. Brain Res Brain Res Rev (2005) 1.04
Novel polyomavirus associated with brain tumors in free-ranging raccoons, western United States. Emerg Infect Dis (2013) 1.03
Effects of JC virus infection on anti-apoptotic protein survivin in progressive multifocal leukoencephalopathy. Am J Pathol (2007) 1.02
Regulatory effect of nerve growth factor in alpha9beta1 integrin-dependent progression of glioblastoma. Neuro Oncol (2008) 1.02
Targeted delivery of antibody conjugated liposomal drug carriers to rat myocardial infarction. Biotechnol Bioeng (2007) 1.01
JCV T-antigen interacts with the neurofibromatosis type 2 gene product in a transgenic mouse model of malignant peripheral nerve sheath tumors. Oncogene (2004) 1.01
Analysis of a mutant p53 protein arising in a medulloblastoma from a mouse transgenic for the JC virus early region. Anticancer Res (2007) 1.01
Polysomnographic findings in children with headaches. Pediatr Neurol (2008) 1.01
A rabbit model of Alzheimer's disease: valid at neuropathological, cognitive, and therapeutic levels. J Alzheimers Dis (2007) 1.00
Insulin receptor substrate 1 translocation to the nucleus by the human JC virus T-antigen. J Biol Chem (2002) 1.00
Leptin and its receptor are overexpressed in brain tumors and correlate with the degree of malignancy. Brain Pathol (2009) 0.99
Spectrum of polysomnographic abnormalities in children with epilepsy. Pediatr Neurol (2008) 0.98
Intravenous levetiracetam in children with epilepsy. Pediatr Neurol (2008) 0.97
p73 Interacts with human immunodeficiency virus type 1 Tat in astrocytic cells and prevents its acetylation on lysine 28. Mol Cell Biol (2005) 0.96
Evidence for involvement of transforming growth factor beta1 signaling pathway in activation of JC virus in human immunodeficiency virus 1-associated progressive multifocal leukoencephalopathy. Arch Pathol Lab Med (2004) 0.96
Aggravation of seizures and/or EEG features in children treated with oxcarbazepine monotherapy. Epilepsia (2007) 0.96
Methotrexate enhances the anti-inflammatory effect of CF101 via up-regulation of the A3 adenosine receptor expression. Arthritis Res Ther (2006) 0.95
Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. I. Class III beta-tubulin. J Cell Physiol (2009) 0.95
Nuclear IRS-1 and cancer. J Cell Physiol (2012) 0.94
Neuroprotective effects of IGF-I against TNFalpha-induced neuronal damage in HIV-associated dementia. Virology (2003) 0.93
Localization of the neuronal class III beta-tubulin in oligodendrogliomas: comparison with Ki-67 proliferative index and 1p/19q status. J Neuropathol Exp Neurol (2002) 0.93
Correlation between child and parental perceptions of health-related quality of life in epilepsy using the PedsQL.v4.0 measurement model. Epileptic Disord (2010) 0.93
Correlates of periodic limb movements of sleep in the pediatric population. Pediatr Neurol (2008) 0.92
Internalization of exogenous human immunodeficiency virus-1 protein, Tat, by KG-1 oligodendroglioma cells followed by stimulation of DNA replication initiated at the JC virus origin. DNA Cell Biol (2004) 0.92
Efficacy and tolerability of topiramate in children younger than 2 years old. J Child Neurol (2005) 0.90
CD4+/CD56+ hematodermic neoplasm: presentation of 2 cases and review of the concept of an uncommon tumor originated in plasmacytoid dendritic cells expressing CD123 (IL-3 receptor alpha). Appl Immunohistochem Mol Morphol (2007) 0.89
T-antigen of human polyomavirus JC cooperates withIGF-IR signaling system in cerebellar tumors of the childhood-medulloblastomas. Anticancer Res (2003) 0.89
Undifferentiated embryonal sarcoma of the liver is associated with mesenchymal hamartoma and multiple chromosomal abnormalities: a review of eleven cases. Pediatr Dev Pathol (2010) 0.89
Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy. Epileptic Disord (2004) 0.88
Developmental expression of Wnt signaling factors in mouse brain. Cancer Biol Ther (2003) 0.88
Molecular biology and immunoregulation of human neurotropic JC virus in CNS. J Cell Physiol (2002) 0.88
Class III beta-tubulin and gamma-tubulin are co-expressed and form complexes in human glioblastoma cells. Neurochem Res (2007) 0.88
Differential expression and cellular distribution of gamma-tubulin and betaIII-tubulin in medulloblastomas and human medulloblastoma cell lines. J Cell Physiol (2010) 0.87
Involvement of the p53 and p73 transcription factors in neuroAIDS. Cell Cycle (2008) 0.87
Identification of HIV-associated progressive multifocal leukoencephalopathy: magnetic resonance imaging and spectroscopy. J Neuropsychiatry Clin Neurosci (2003) 0.86
PDZ-RhoGEF is essential for CXCR4-driven breast tumor cell motility through spatial regulation of RhoA. J Cell Sci (2013) 0.86
TCH346 prevents motor symptoms and loss of striatal FDOPA uptake in bilaterally MPTP-treated primates. Neurobiol Dis (2003) 0.86
Novel expression of PINCH in the central nervous system and its potential as a biomarker for human immunodeficiency virus-associated neurodegeneration. J Neurosci Res (2008) 0.85
Radiation-guided targeting of combretastatin encapsulated immunoliposomes to mammary tumors. Pharm Res (2009) 0.85
Vagus nerve stimulation in children with refractory epilepsy: unusual complications and relationship to sleep-disordered breathing. Childs Nerv Syst (2007) 0.85
Negative regulation of AbetaPP gene expression by pur-alpha. J Alzheimers Dis (2008) 0.85
Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. II. gamma-Tubulin. J Cell Physiol (2009) 0.85
Cross-interaction between JC virus agnoprotein and human immunodeficiency virus type 1 (HIV-1) Tat modulates transcription of the HIV-1 long terminal repeat in glial cells. J Virol (2006) 0.84
Efficacy and safety of zonisamide monotherapy in a cohort of children with epilepsy. Pediatr Neurol (2006) 0.83
Insulin-like growth factor-I-forkhead box O transcription factor 3a counteracts high glucose/tumor necrosis factor-α-mediated neuronal damage: implications for human immunodeficiency virus encephalitis. J Neurosci Res (2010) 0.83
IGF-IR in neuroprotection and brain tumors. Front Biosci (Landmark Ed) (2009) 0.83